These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7529041)

  • 1. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata.
    Mashal RD; Fejzo ML; Friedman AJ; Mitchner N; Nowak RA; Rein MS; Morton CC; Sklar J
    Genes Chromosomes Cancer; 1994 Sep; 11(1):1-6. PubMed ID: 7529041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation.
    Quade BJ; McLachlin CM; Soto-Wright V; Zuckerman J; Mutter GL; Morton CC
    Am J Pathol; 1997 Jun; 150(6):2153-66. PubMed ID: 9176406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
    Xing YP; Powell WL; Morton CC
    Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.
    Quade BJ; Dal Cin P; Neskey DM; Weremowicz S; Morton CC
    Mod Pathol; 2002 Mar; 15(3):351-6. PubMed ID: 11904348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse leiomyomatosis of the uterus: a case report with clonality analysis.
    Baschinsky DY; Isa A; Niemann TH; Prior TW; Lucas JG; Frankel WL
    Hum Pathol; 2000 Nov; 31(11):1429-32. PubMed ID: 11112221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
    Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
    Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic abnormalities in uterine leiomyomata.
    Rein MS; Friedman AJ; Barbieri RL; Pavelka K; Fletcher JA; Morton CC
    Obstet Gynecol; 1991 Jun; 77(6):923-6. PubMed ID: 2030869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis.
    Patton KT; Cheng L; Papavero V; Blum MG; Yeldandi AV; Adley BP; Luan C; Diaz LK; Hui P; Yang XJ
    Mod Pathol; 2006 Jan; 19(1):130-40. PubMed ID: 16357844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics of uterine leiomyomata].
    Pedeutour F; Ligon AH; Morton CC
    Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis.
    Canevari RA; Pontes A; Rosa FE; Rainho CA; Rogatto SR
    Am J Obstet Gynecol; 2005 Oct; 193(4):1395-403. PubMed ID: 16202732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality of basal cell carcinoma--molecular analysis of an interesting case.
    Walsh DS; Tsou HC; Harrington A; James WD; Peacocke M
    J Invest Dermatol; 1996 Mar; 106(3):579-82. PubMed ID: 8648198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation.
    Moniz S; Catarino AL; Marques AR; Cavaco B; Sobrinho L; Leite V
    Eur J Endocrinol; 2002 Jan; 146(1):27-33. PubMed ID: 11751063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality assessment of adenomatoid tumor supports its neoplastic nature.
    Wang W; Zhu H; Wang J; Wang S; Wang D; Zhao J; Zhu H
    Hum Pathol; 2016 Feb; 48():88-94. PubMed ID: 26772404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of disseminated peritoneal leiomyomatosis developing after laparoscope-assisted myomectomy.
    Miyake T; Enomoto T; Ueda Y; Ikuma K; Morii E; Matsuzaki S; Murata Y
    Gynecol Obstet Invest; 2009; 67(2):96-102. PubMed ID: 18946223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic aberrations and the development of uterine leiomyomata.
    El-Gharib MN; Elsobky ES
    J Obstet Gynaecol Res; 2010 Feb; 36(1):101-7. PubMed ID: 20178534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue.
    Mashal RD; Lester SC; Sklar J
    Cancer Res; 1993 Oct; 53(19):4676-9. PubMed ID: 8402645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent origin of uterine leiomyomas with karyotypically identical alterations.
    Nilbert M; Strömbeck B
    Gynecol Obstet Invest; 1992; 33(4):246-8. PubMed ID: 1505817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles.
    Fujimoto J; Hirose R; Sakaguchi H; Tamaya T
    Tumour Biol; 2000; 21(1):33-7. PubMed ID: 10601839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas.
    Cai YR; Diao XL; Wang SF; Zhang W; Zhang HT; Su Q
    Int J Oncol; 2007 Dec; 31(6):1379-89. PubMed ID: 17982665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.